(Q48910243)

English

Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre- and postsynaptic dopamine receptors in rat brain

scientific article published on August 19, 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/6289974

Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre- and postsynaptic dopamine receptors in rat brain (English)

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

4

object named as

Fahn S

1 reference

Europe PubMed Central

16 February 2018

author name string

A. Reches

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289974

18 September 2023

H. R. Wagner

2

0000-0003-3954-6556

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289974

18 September 2023

V. Jackson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289974

18 September 2023

language of work or name

0 references

publication date

1 August 1982

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/6289974

19 August 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6289974

18 September 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0006899382901603?httpAccept=text/xml

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

https://api.elsevier.com/content/article/PII:0006899382901603?httpAccept=text/plain

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/6289974

246

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/6289974

1

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/6289974

172-177

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/6289974

The effect of lithium on chronic haloperidol enhanced apomorphine aggression in rats

1

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

4

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo.

5

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Lithium therapy in Huntington's chorea and tardive dyskinesia

6

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Strategies for determination of serum or plasma norepinephrine by reverse-phase liquid chromatography

7

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

The effect of long-term lithium treatment on reserpine-induced supersensitivity in dopaminergic and serotonergic transmission

9

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium

10

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol

12

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine

13

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine or haloperidol

15

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.

16

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping

17

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

The pharmacology of tardive dyskinesias

19

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

An experimental model of tardive dyskinesia

20

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

The effect of lithium on an animal model of tardive dyskinesia

21

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Protein measurement with the Folin phenol reagent

22

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Failure of lithium treatment in established tardive dyskinesia

23

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels

24

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

25

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity

28

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.

29

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Letter: Fenfluramine and dyskinesias

30

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

The effect of imipramine and lithium on α- and β-receptor binding in rat brain

31

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Chronic lithium reduces [3H]spiroperidol binding in rat striatum

32

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

33

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Increased in vivo binding of 3H-Pimozide in mouse striatum following repeated administration of haloperidol

35

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Increase in mesolimbic electrical self-stimulation after chronic haloperidol: reversal by L-DOPA or lithium

36

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

37

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Lithium in tardive dyskinesia

38

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

39

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity.

41

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity

42

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

43

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Stereotaxic mapping of the monoamine pathways in the rat brain.

44

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity

45

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors

46

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Supersensitivity of caudate neurones after repeated administration of haloperidol

48

1 reference

10.1016/0006-8993(82)90160-3

https://api.crossref.org/works/10.1016/0006-8993(82)90160-3

18 September 2023

Identifiers

10.1016/0006-8993(82)90160-3

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/6289974

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/6289974

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48910243&oldid=1976536746"